Insider Selling: Phreesia, Inc. (NYSE:PHR) General Counsel Sells 3,496 Shares of Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 3,496 shares of the stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $25.32, for a total value of $88,518.72. Following the sale, the general counsel now owns 139,134 shares of the company’s stock, valued at $3,522,872.88. This represents a 2.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Phreesia Stock Down 4.9 %

Shares of NYSE:PHR opened at $27.59 on Friday. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53. The firm has a market capitalization of $1.62 billion, a P/E ratio of -18.77 and a beta of 1.03. The stock has a 50 day moving average price of $27.32 and a 200-day moving average price of $24.06. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in PHR. Zacks Investment Management bought a new position in Phreesia during the 3rd quarter valued at approximately $631,000. State Street Corp increased its position in Phreesia by 7.1% during the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after buying an additional 88,517 shares in the last quarter. Wesbanco Bank Inc. increased its position in Phreesia by 76.9% during the 4th quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock valued at $1,157,000 after buying an additional 20,000 shares in the last quarter. Barclays PLC increased its position in Phreesia by 83.6% during the 3rd quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after buying an additional 43,225 shares in the last quarter. Finally, Franklin Resources Inc. increased its position in Phreesia by 3.0% during the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after buying an additional 42,973 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on PHR shares. Robert W. Baird dropped their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Citigroup increased their price objective on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Truist Financial increased their price objective on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price objective on shares of Phreesia in a report on Tuesday, December 10th. Finally, Canaccord Genuity Group increased their price objective on Phreesia from $34.00 to $35.00 and gave the stock a “buy” rating in a report on Thursday, March 13th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $31.33.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.